|
|
Volumn 146, Issue 3, 2002, Pages 527-528
|
|
Subclinical, primary antiphospholipid syndrome unmasked by sclerotherapy [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
BETA2 GLYCOPROTEIN 1;
LUPUS ANTICOAGULANT;
MEMBRANE ANTIGEN;
ORAL CONTRACEPTIVE AGENT;
PHOSPHOLIPID ANTIBODY;
PHOSPHOLIPID BINDING PROTEIN;
POLIDOCANOL;
SALICYLIC ACID;
STEROID;
VIPER VENOM;
ADULT;
ANTICOAGULANT THERAPY;
ANTIPHOSPHOLIPID SYNDROME;
BLEEDING;
BLOOD CLOTTING TIME;
BLOOD VESSEL INJURY;
CASE REPORT;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
INFARCTION;
INJECTION SITE;
LETTER;
PAIN;
PRIORITY JOURNAL;
SCLEROTHERAPY;
SKIN DEFECT;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TELANGIECTASIA;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
THROMBOPHILIA;
THROMBOPLASTIN TIME;
THROMBOSIS;
ULCER;
VASCULAR ENDOTHELIUM;
ANTIPHOSPHOLIPID SYNDROME;
FEMALE;
HUMANS;
LEG;
LEG ULCER;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
SCLEROTHERAPY;
TELANGIECTASIS;
|
|
EID: 0036284604
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.2002.46323.x Document Type: Letter |
|
Times cited : (7)
|
|
References (5)
|
